The Neuropharmacological Background of Antidepressant Drugs
- 31 March 1966
- journal article
- Published by Elsevier in Psychosomatics
- Vol. 7 (2), 99-105
- https://doi.org/10.1016/s0033-3182(66)72177-x
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Inhibition of Uptake of Tritiated-noradrenaline in the Intact Rat Brain by Imipramine and Structurally Related CompoundsNature, 1964
- EVIDENCE FOR A FALSE NEUROCHEMICAL TRANSMITTER AS A MECHANISM FOR THE HYPOTENSIVE EFFECT OF MONOAMINE OXIDASE INHIBITORSProceedings of the National Academy of Sciences, 1964
- Concept of the Neurochemical Transducer as an Organized Molecular Unit at Sympathetic Nerve EndingsPublished by Elsevier ,1964
- Association of behavoural effects of pargyline, a non-hydrazide mao inhibitor with increase in brain norepinephrineInternational Journal of Neuropharmacology, 1963
- Turnover rates of norepinephrine in hearts of intact mice, rats and guinea pigs using tritiated norepinephrineLife Sciences, 1963
- The uptake of labeled norepinephrine by isolated brain and other tissues of the catInternational Journal of Neuropharmacology, 1962
- MICROANALYTICAL PROCEDURES FOR FLUORO‐METRIC ASSAY OF BRAIN DOPA‐5HTP DECARBOXYLASE, NOREPINEPHRINE AND SEROTONIN, AND A DETAILED MAPPING OF DECARBOXYLASE ACTIVITY IN BRAINJournal of Neurochemistry, 1961
- 3,4-Dihydroxyphenylalanine and 5-Hydroxytryptophan as Reserpine AntagonistsNature, 1957